Endothelin receptor antagonists: which are the therapeutic perspectives in renal diseases?

被引：14

作者：

Benigni, A ^{[1
]}

Remuzzi, G ^{[1
]}

机构：

[1] Mario Negri Inst Pharmacol Res, I-24125 Bergamo, Italy

来源：

NEPHROLOGY DIALYSIS TRANSPLANTATION | 1998年 / 13卷 / 01期

关键词：

D O I：

10.1093/ndt/13.1.5

中图分类号：

R3 [基础医学]; R4 [临床医学];

学科分类号：

1001 ; 1002 ; 100602 ;

摘要：

Since the discovery of endothelin peptides, much interdisciplinary research looked into their unique profile as powerful and long-lasting vasoconstrictors and mitogens. On account of the renal vasculature's sensitivity to endothelin-l and the peptide's various effects on the kidney, the role of endothelin-l in the control of kidney function has attracted particular attention.

引用

页码：5 / 7

页数：3

共 50 条

[21] Endothelin receptor antagonists
Nelson, JB
WORLD JOURNAL OF UROLOGY, 2005, 23 (01) : 19 - 27
[22] Endothelin receptors: Receptor classification, novel receptor antagonists, and potential therapeutic targets
Ohlstein, EH
Elliott, JD
Feuerstein, GZ
Ruffolo, RR
MEDICINAL RESEARCH REVIEWS, 1996, 16 (04) : 365 - 390
[23] Endothelin receptor antagonists
Terrett, N
DRUG DISCOVERY TODAY, 1997, 2 (11) : 500 - 500
[24] Endothelin receptor antagonists
Xiang, JN
Luengo, JI
Ohlstein, EH
Elliott, JD
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1999, 217 : U1195 - U1195
[25] Endothelin receptor antagonists
Edwards, P
DRUG DISCOVERY TODAY, 2001, 6 (16) : 861 - 862
[26] The endothelin system and endothelin receptor antagonists
Jandeleit-Dahm, Karin A. M.
Watson, Anna M. D.
CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION, 2012, 21 (01): : 66 - 71
[27] Endothelin receptor antagonists
Cheng, TO
CIRCULATION, 1997, 96 (10) : 3813 - 3813
[28] Endothelin receptor antagonists
Joel B. Nelson
World Journal of Urology, 2005, 23 : 19 - 27
[29] Endothelin Receptor Antagonists: Status Quo and Future Perspectives for Targeted Therapy
Enevoldsen, Frederik C.
Sahana, Jayashree
Wehland, Markus
Grimm, Daniela
Infanger, Manfred
Krueger, Marcus
JOURNAL OF CLINICAL MEDICINE, 2020, 9 (03)
[30] Angiotensin II receptor antagonists (AIIRA): which drug combinations and which perspectives
Ambrosioni, E
DISEASE MANAGEMENT & HEALTH OUTCOMES, 2005, 13 : 5 - 8

← 1 2 3 4 5 →